ACRS vs CMS · rev $18.7M vs P/E 20, $22.42B cap
Aclaris Therapeutics Inc (ACRS) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported ACRS revenue for 2024-12-31 was $18.7M. Net income was -$132.1M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. ACRS currently screens at market cap $615.9M.
CMS does not have a complete income-statement cache yet.
ACRS currently screens at market cap $615.9M. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the ACRS and CMS stock pages for the full models.
Not investment advice.